MULTIPLE mnyeloma, both in man (Fahey et al., 1963; Cone and Uhr, 1964; Dammaco and Clausen, 1966) and the mouse (Smith et al., 1960; Fahey and Humphrey, 1962; Hirano et al., 1968; Zolla et al., 1974) often produces a marked humoral immunodepression. Associated with this depressed antibody response is the tendency of patients with myeloma to fall victim to infectious diseases (Fahey et al., 1963; Zinneman and Wall, 1964; Scharff and Uhr, 1965; Meyers et al., 1972) . The mechanism of this humoral immunodepression is the subject of considerable controversy.
Hypotheses advanced to explain the humoral immunodepression of myeloma fall into two broad classes: those attributing it to a circulating immnunodepressive factor, and those invoking a defect in the antibody-producing cells themselves. Proponents of the existence of circulating immunodepressive factors have suggested that these may be viral R1NA (Heller et al., 1973; Chen et al., 1975) or a chalonelike substance . The role of the myeloma protein in the causation of this humoral immunodepression is questionable, since there is no correlation between the type or quantity of the monoclonal protein and the impairment of the antibody response (Fahey et al., 1963) . Plasmacytomas that do not secrete any monoclonal immunoglobulins can also cause humoral immunodepression (Zolla, 1972) . Other authors have presented evidence suggesting a defect at the cellular level (Jones and McFarlane, 1975; Padarathsingh et al., 1976) . Our preliminary studies have revealed that, unlike normal mice, those bearing certain plasmacytomas do not respond to antigenic stimulation with an increase in spleen lymphocytes (Brus et al., 1975) . This phenomenon could be due to an impaired recall of lymphocytes to the spleen, or alternatively, an inability of lymphocytes to proliferate in response to stimulation.
The present studies were undertaken to determine whether the lack of increase in spleen lymphocytes following immunization with sheep red blood cells (SRBC) is related to an inability to respond to mitogenic stimulation. This was evaluated using mitogens specific for B-and T-cell subpopulations. The results presented here indicate a cellular defect in the lymphocytes of plasmacytoma-bearing mice.
MATERIALS AND METHODS
Tumours.-The following mouse myelomas, all of BALB/c origin, were used: TEPC-183 and SPQC-11, both of which cause an impaired antibody response, and MOPC-315 and MPC-11, which do not cause humoral immunodepression. TEPC-183 produces an IgM (k) protein, SPQC-11 and MPC-11 both produce an IgG2b (k) protein, and MOPC-315 produces an IgA (k) protein.
Immunoglobulin production of these tumours was monitored by immunoelectrophoresis. These tumours were maintained by s.c. inoculation of 0-15 ml of tumour-cell suspension into BALB/c female mice. TEPC-183 and SPQC-11 were kindly given to us by Dr Susan Zolla-Pazner of the V. A. Hospital, New York University Medical School; MOPC-315 was given to us by Dr Herman Eisen of the Massachusetts Institute of Technology; and MPC-1 1 was a gift from Dr Matthew Scharff of the Albert Einstein School of Medicine.
Serum.-Blood was collected from the axillary artery. After clotting, the serum was collected by centrifugation and used immediately.
Immunization. plastic syringe plunger into a sterile cold RPMI-1640 medium supplemented with penicillin (100 ,ug/ml), streptomycin (50 ,tg/ml) and glutamine (3 ,uM/ml). The cells were passed several times through a 20-gauge needle to eliminate clumps, and washed with cold medium. The spleen-cell suspension was layered on a Hypaque-Ficoll gradient (1 078 density) and centrifuged for 40 min at room temperature at 400g. Cells were removed from the interphase with a Pasteur pipette and washed twice with medium at 100g for 10 min. Smears of these cells, stained with WVright's stain, showed that 94-98% of this population were morphologically identifiable as lymphocytes. The remaining fraction of cells were monocytes. Similar results were obtained by examination of these cells by phase microscopy, where lymphocytes were differentiated from monocytes by the ability of the latter to ingest latex particles. The lymphocyte count and viability were determined on a Biophysics Cytograf 6300A and expressed as total lymphocyte count per spleen (TLC/S). The viability ranged from 89 to 96%. Imprints and frozen sections of the spleens were taken and stained with Wright's or haematoxylineosin (HE) stain, respectively. Mitogenic 8timulation.-Lymphocytes were prepared as previously described. Pooled lymphocytes isolated from 5-8 spleens in each group were used. All cultures were set up in triplicate in flat-bottomed microplates (3040 Microtest II, Falcon Plastics).
The final culture volume was 0-2 ml containing 106 lymphocytes per well. PHA-P was obtained from Difco Laboratories, Detroit, Mich. (48232) . The final concentration of PHA-P was 5 jig/well. This dose gave optimal stimulation as determined by a dose-response curve.
Lipopolysaccharide LPS (E. coli 055: B5) from Difco Laboratories was used in a final concentration of 30 ,ug/well, this dose gave the optimal stimulation.
All wells containing PHA-P were supplemented with 5% fresh, decomplemented
Millipore-filtered pooled mouse serum. The optimal LPS response was obtained without addition of serum. Serum was only used with this mitogen when comparing the effect of serum from normal and plasmacytoma-bearing mice.
Microplates 
RESULTS
Effect of mouse plasmacytomao n spleen lymphocytes After immunization, non-tumour-bearing mice showed >100% increase in TLC/S compared to mice injected with saline only (Table I ). The haemolysin titres of immunized normal mice were always in the range of 6-10 (log 2). Mice bearing plasmacytomas TEPC-183 and SPQC-l1 show a markedly impaired antibody response. Associated with this immunodepression is a lack of an increase in TLC/S following antigen stimulation.
Mice bearing tumour MPC-I 1, which does not interfere with the antibody response, showed a marked increase in TLC/S following immunization.
Mice bearing the plasmacytoma MOPC-315 demonstrate a normal or sometimes Mice bearing plasmacytomas had markedly enlarged spleens, ranging from 160 to 690 mg. Normal mouse spleens averaged 110 mg. However, there was no correlation between spleen lymphocyte count and spleen weight. No metastatic tumour was seen in the spleens upon macroscopic examination. Imprints and frozen sections of spleens from all plasmacytoma-bearing mice showed the presence of some tumour cells. However, the number of tumour cells present was negligible compared to the total lymphocytes. The splenomegaly of tumour-bearing mice correlated with an increase in total leucocytes, erythrocytes and platelets in their spleens.
PHA stimulation of lymphocytes
Lymphocytes from all plasmacytomabearing mice showed a markedly impaired ability to respond to PHA relative to those from normal mice. As shown in Table II , the net amount of TdR incorporated by lymphocytes from tumour-bearing mice was less than that of cells from normal mice. Lymphocytes from both MOPC-315 and SPQC-11 showed an actual decrease in TdR incorporation relative to nonstimulated lymphocytes from mice bearing these tumours. Lymphocytes from mice with TEPC-183 showed no difference between stimulated and unstimulated The experiments were performed as described for Table II . The cells were incubated with either 5% normal mouse serum or 5% serum from tumour-bearing mice. Mean±s.e. These experiments were performed as described for (Marks, 1953; Lawson et al., 1955) . Several studies have shown that mice bearing the plasmacytomas TEPC-183 and SPQC-11 have a markedly impaired primary response, as shown by decreased number of plaqueforming cells after immunization with SRBC (Zolla, 1972; .
In our own studies, normal mice show an increase of both TLC/S and antibody titres after SRBC injection (Table I) . However, the plasmacytomas TEPC-183 and SPQC-1 1 cause a depressed antibody response and lack of spleen lymphocyte increase after SRBC immunization. As shown in Table I In order to determine whether the lack of an increase of spleen lymphocytes following immunization of mice bearing the humorally immunodepressive plasmacytomas is due to inability to proliferate when stimulated, we evaluated their response to mitogens specific for B-and Tcell subpopulations. Mitogenic response can be evaluated by stimulation index, total number of counts incorporated, or the net increase in the number of counts following mitogenic stimulation. It is important to stress that stimulation indices are only useful when comparing the stimulation of similar populations of cells. Under these conditions, the denominator (ct/min unstimulated) remains constant, and the only variable is the numerator (ct/min stimulated). However, in our studies, marked differences in the TdR incorporation of unstimulated cultures make the stimulation index an ambiguous parameter. A more useful parameter is the net increase (ct/min stimulated-ct/min unstimulated) in TdR incorporation following mitogenic stimulation. While our results (Tables II-V) are given as all 3 of the parameters listed above, interpretations were made using the net increase in counts.
PHA is known to be a T-cell mitogen in mice (Dukor and Dietrich, 1967; Doenhoff et al., 1970; Andersson and Blomgren, 1971; Blomgren and Svermyr, 1971 (Jones and MacFarlane, 1975) . It should be noted that the impaired response to PHA may not be related to the humoral immunodepression associated with myelomas, since our data indicate that the response to this mitogen was depressed even in the lymphocytes from plasmacytoma-bearing mice capable of a normal antibody response to SRBC, a T-cell-dependent antigen.
B-lymphocyte function was evaluated with LPS, a B-cell mitogen (Peavy et al., 1970; Gery et al., 1972) . The results of LPS stimulation of lymphocytes correlate with the data presented on lymphocyte proliferation after immunization with SRBC. Immunization of mice bearing MOPC-315, TEPC-183, and SPQC-11 does not result in an increase in total spleen lymphocytes, nor do mice bearing these tumours respond normally to LPS stimulation. Lymphocytes from mice bearing MPC-11, which had a significant increase in total spleen lymphocytes following immunization, show normal amounts of TdR incorporated after LPS stimulation (Tables I and III) . The presence of some tumour cells in the preparation of lymphocytes from plasmacytoma-bearing mice may be related to the high basal TdR incorporation of unstimulated cultures (Tables II and III) . However, it is unlikely that this elevated TdR incorporation in unstimulated cultures from plasmacytoma-bearing animals is due to the metabolism of tumour cells, since spleen imprints show only a small proportion of the cells to be morphologically identifiable as tumour cells. Nevertheless, these malignant plasma cells may serve as a constant antigenic stimulus to the lymphocytes. It has been shown that in vivo administration of antigen to normal mice causes transient inhibition of the PHA response of their spleen cells in vitro (Gershon et al., 1974) . We are now studying the possible role of metastatic tumour cells in the impairment of lymphocytes after mitogenic or antigenic stimulation.
Sera from plasmacytoma-bearing mice do not adversely affect the mitogen response of lymphocytes to both mitogens (Table IV and V). The presence of humoral immunosuppressive factors in multiple myeloma has been proposed (Zolla, 1972; Zolla et al., 1974) ; Tanapatchaiyapong and Zolla, 1974) . However, we could find no evidence of suppressive factor(s) in our system. Thus, if such a factor exists in serum from plasmacytoma-bearing mice, it may be very unstable or present in ineffective concentrations in the experimental system used. We could not evaluate the effect of higher serum concentrations, as these proved to be inhibitory to our cultures. However, our results presented here on the mitogenic response of lymphocytes from plasmacytoma-bearing mice suggest a cellular site of the defect in plasmacytoma.
At present, we are continuing our search for immunosuppressive factors in the serum, using diffusion chambers in vivo and serum fractions in vitro. We are evaluating the response of lymphocytes from plasmacytoma-bearing animals to antigenic stimulation in vitro, using defined lymphocyte and monocyte populations.
